Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Fuith

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Anticancer Research|March 1, 1989
Effects of biological response modifiers on ovarian carcinoma cell linesC Marth, M Helmberg, I Mayer, et al.
Lancet (London, England)|June 3, 1989
Interactions between haemopoietic growth factorsD Fuchs, E Artner-Dworzak, L C Fuith, et al.
Cancer Research|August 1, 1984
Depression of histone acetylation by alkylating antitumor agents in murine cellsH Zwierzina, A Loidl, L C Fuith, et al.
Lancet (London, England)|April 29, 1989
Parity as prognostic factor for malignant mixed müllerian tumoursC Marth, A Koza, E Müller-Holzner, et al.
Geburtshilfe Und Frauenheilkunde|February 1, 1990
[Modulation of hCG synthesis by alpha tumor necrosis factor in JAR choriocarcinoma cells]C Marth, S Madersbacher, M Herold, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1992
[Prognostic significance of tumor markers in cervix cancer]C Marth, A G Zeimet, L C Fuith, et al.
Gynakologische Rundschau|January 1, 1989
[Detection of papillomavirus types 6/11, 16/18 and 31/33/35 using DNA/RNA hybridization. Initial experiences]B Wartusch, D Weiss, K Heim, et al.
Anticancer Research|September 2, 1999
Increased neopterin concentrations in patients with cancer: indicator of oxidative stress?C Murr, L C Fuith, B Widner, et al.
Geburtshilfe Und Frauenheilkunde|August 1, 1990
[Prognostically relevant factors in malignant mixed Müllerian tumor]C Marth, A Koza, E Müller-Holzner, et al.
The International Journal of Biological Markers|April 1, 1989
Distribution of CA 125 in placental tissuesL C Fuith, E Müller-Holzner, C Marth, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Anticancer Research|March 1, 1989
Effects of biological response modifiers on ovarian carcinoma cell linesC Marth, M Helmberg, I Mayer, et al.
Lancet (London, England)|June 3, 1989
Interactions between haemopoietic growth factorsD Fuchs, E Artner-Dworzak, L C Fuith, et al.
Cancer Research|August 1, 1984
Depression of histone acetylation by alkylating antitumor agents in murine cellsH Zwierzina, A Loidl, L C Fuith, et al.
Lancet (London, England)|April 29, 1989
Parity as prognostic factor for malignant mixed müllerian tumoursC Marth, A Koza, E Müller-Holzner, et al.
Geburtshilfe Und Frauenheilkunde|February 1, 1990
[Modulation of hCG synthesis by alpha tumor necrosis factor in JAR choriocarcinoma cells]C Marth, S Madersbacher, M Herold, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1992
[Prognostic significance of tumor markers in cervix cancer]C Marth, A G Zeimet, L C Fuith, et al.
Gynakologische Rundschau|January 1, 1989
[Detection of papillomavirus types 6/11, 16/18 and 31/33/35 using DNA/RNA hybridization. Initial experiences]B Wartusch, D Weiss, K Heim, et al.
Anticancer Research|September 2, 1999
Increased neopterin concentrations in patients with cancer: indicator of oxidative stress?C Murr, L C Fuith, B Widner, et al.
Geburtshilfe Und Frauenheilkunde|August 1, 1990
[Prognostically relevant factors in malignant mixed Müllerian tumor]C Marth, A Koza, E Müller-Holzner, et al.
The International Journal of Biological Markers|April 1, 1989
Distribution of CA 125 in placental tissuesL C Fuith, E Müller-Holzner, C Marth, et al.
Pageof 7